Skip to content

AWM PHARMA

Active
Private limited company·Activiteiten van holdings· 2 yrs active
Vlaamsesteenweg 4 ·1000 Brussel, Belgium
KBO/BCE: BE 1005.406.780
Watch Print / PDF
Age2 yrs

Summary

Conclusion

the dossier summarised in one paragraph

AWM PHARMA is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2024 annual accounts show equity of €168k and a net result of €68k. Its solvency ranks better than 21% of 678 sector peers (fiscal year 2024). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 1 annual account.

Signals

1 signal · with evidence
Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 21% of 678 sector peers (2024).
View the sector comparison

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Trust signals

3 signals
Young company
Founded in 2024, under 3 years, statistically higher risk.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

This is a financial institution (bank, insurer or financial holding). Our bankruptcy model is trained on ordinary trading and manufacturing companies; a bank balance sheet falls outside that scope. We therefore show no bankruptcy probability rather than a misleading figure.

Financials

Equity€168k
Net result€68k
Total assets€1.30M
Solvency12.9%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 01-07-2025 with the NBB · fiscal year 2024 · volledig
Sector comparison
Fiscal year 2024 · NACE 64, Financial services · compared within the same schema type (full schema)
Metric This company Sector median Position in the sector
Solvency 12.9% 44.9%
better than 21% of 678 sector peers
Net result €68k €48k
better than 55% of 677 sector peers
Equity €168k €1.36M
better than 26% of 678 sector peers
Gross operating margin €101k €42k
better than 71% of 370 sector peers
Total assets €1.30M €5.58M
better than 30% of 678 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Fiscal year2024
Revenuen/a
EBITDAn/a
Net profit€68k
Cash flown/a
Staff costs-
Income taxes€17k
Dividends-
Total assets€1.30M
Equity€168k
Debt€1.13M
of which ≤ 1y€477k
of which > 1y€655k
Working capitaln/a
Employees (FTE)-
Ratios (computed)
2024
Current ration/a
Quick ration/a
Working capital ration/a
Solvency12.9%
Debt / equityn/a
Long-term debt ration/a
Interest coveragen/a
Gross marginn/a
Net marginn/a
ROA5.2%
ROE40.4%
EBITDA marginn/a
Days sales outstandingn/a
Days payable outstandingn/a
Inventory turnovern/a
Days inventory (DSI)n/a
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€1.30M
Fixed assets 21/28€1.25M
Financial fixed assets 28€1.25M
Current assets 29/58€49k
Amounts receivable within one year 40/41€45k
Cash & bank 54/58€5k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€1.30M
Equity 10/15€168k
Contributions / capital 10/11€100k
Accumulated profits (losses) 14€68k
Amounts payable 17/49€1.13M
Amounts payable after one year 17€655k
Amounts payable within one year 42/48€477k
Trade debts payable within one year 44€230
Income statement
Gross operating margin 9900€101k
Operating result 9901€99k
Financial charges 65€15k
Result before taxes 9903€85k
Income taxes 67/77€17k
Net result for the period 9904€68k
Result to be appropriated 9905€68k
Ratios computed by Checked.

Health barometer

FY 2024 · computed
Model not applicable to financial institutions
The health score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here.

Structure & network

Locations & real estate

Establishment units

1 location
PHARMA 4
Vlaamsesteenweg 4, 1000 BrusselDetailhandel in farmaceutische producten
since 20242.355.118.230
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area94 m²
Buildings1
Building footprint94 m²
Volume (LiDAR)1,366 m³
Tallest building18.4 m · ±5 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21811M0539/00A000 Brussels 94 m² 1 · 94 m² 18.4 m · 5 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Analysis

Snowflake analysis

financial profile on 5 axes
Health0Profitability100Solvency9Growth50Stability67
45 / 100

Mixed profile: strong on profitability, weaker on health.

Health 0
Profitability 100
Solvency 9
Growth 50
Stability 67

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, ranked by comparable size

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Holdings64200Activiteiten van holdings64210Apotheken47730Detailhandel in farmaceutische producten47730Overige zakelijke dienstverlening, n.e.g.82990Overige zakelijke dienstverlening, neg82990
Primary activity highlighted.
Names & trade names
Legal nameFR AWM PHARMA
Registered office
Vlaamsesteenweg 4 bus 2
1000 Brussel, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.